Skip to main content
RUA LIFE SCIENCES PLC logo

RUA LIFE SCIENCES PLC — Investor Relations & Filings

Ticker · RUA ISIN · GB0033360586 LEI · 213800BMVB22PVOJ9Z28 IL Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2026-03-17 Declaration of Voting R…
Country GB United Kingdom
Listing IL RUA

About RUA LIFE SCIENCES PLC

https://rualifesciences.com/

RUA Life Sciences is a medical device group focused on the application of its proprietary long-term implantable polymer, Elast-Eon™, a biostable polyurethane. The company operates through four integrated businesses to develop, manufacture, and license medical device solutions. RUA Biomaterials is responsible for licensing the Elast-Eon™ technology. RUA Medical provides end-to-end contract development and manufacturing services, specializing in implantable fabrics. RUA Vascular develops large-bore, polymer-sealed vascular grafts and soft tissue patches. RUA Structural Heart is engaged in the development of next-generation tri-leaflet polymeric heart valves. The group's collective mission is to improve patient outcomes by enabling and enhancing medical devices through its advanced polymer technology.

Recent filings

Filing Released Lang Actions
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement from RUA Life Sciences plc regarding the 'Result of AGM'. It provides a detailed table of voting results for various resolutions passed during the Annual General Meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2026-03-17 English
AGM Statement and Trading Update
Regulatory Filings Classification · 1% confidence The document is an RNS announcement titled 'AGM Statement and Trading Update' issued by RUA Life Sciences PLC. It provides a summary of business developments and trading performance to coincide with the company's Annual General Meeting. While it mentions the AGM, it is not the full presentation or materials (AGM-R), but rather a regulatory announcement summarizing the company's status at the time of the meeting. Given the specific content regarding trading updates and business developments, it fits the definition of an AGM-related statement provided via a regulatory news service.
2026-03-17 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 2,500 characters) from RUA Life Sciences PLC stating that the Annual Report and Accounts and the Notice of Annual General Meeting have been posted to shareholders and are available on the company website. Per the 'Menu vs Meal' rule, this is an announcement of the availability of reports rather than the reports themselves, making it a Report Publication Announcement (RPA).
2026-02-12 English
Final results for period ended 30 September 2025
Audit Report / Information Classification · 1% confidence The document is an 'RNS' (Regulatory News Service) announcement from RUA Life Sciences PLC. It contains the 'Final results for the period ended 30 September 2025', including financial highlights, a Chairman's Statement, and a Business Review. While it contains the content of an annual report, it is presented as an RNS announcement (indicated by the RNS number and the header 'National Storage Mechanism'). According to the 'Menu vs Meal' rule, since this is an announcement of the results and provides a link to the full report, it is classified as a Report Publication Announcement. FY 2025
2026-01-30 English
Cancellation & Reissue Share Options
Director's Dealing Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from RUA Life Sciences PLC regarding the cancellation and re-grant of share options for PDMRs (Persons Discharging Managerial Responsibilities). While it contains details about share options, the primary purpose is to report transactions by company directors/executives, which falls under the 'Director's Dealing' category. The document includes the mandatory PDMR notification table required for such disclosures.
2025-12-10 English
Trading update
Earnings Release Classification · 1% confidence The document is a 'Trading update' issued by RUA Life Sciences plc. It provides preliminary financial highlights (revenue, EBITDA, cash position) for the 18-month period ending 30 September 2025, ahead of the full audited accounts. It explicitly states that the full audited accounts are expected to be published later (January 2026). According to the filing definitions, an initial announcement of financial results (key highlights only) is classified as an Earnings Release (ER). FY 2025
2025-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.